The new-generation degrader, GLB-002, achieves highly selective degradation of IKZF1/3 proteins, demonstrating promising anti-proliferative activity in vitro in resistant cell lines of NHL and MM. This evidence concerns the gene IKZF1 and non-Hodgkin lymphoma.